Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cerevel Therapeutics Holdings, Inc. stock logo
CERE
Cerevel Therapeutics
$44.96
$43.67
$19.59
$44.99
$8.19B1.41.71 million shsN/A
Core Natural Resources, Inc. stock logo
CNR
Core Natural Resources
$73.02
-1.1%
$71.60
$58.19
$134.59
$3.85B0.69999,280 shs626,481 shs
CNX Resources Co. stock logo
CNX
CNX Resources
$33.10
+1.4%
$31.16
$23.63
$41.93
$4.79B0.662.63 million shs1.75 million shs
Warrior Met Coal, Inc. stock logo
HCC
Warrior Met Coal
$46.86
+0.2%
$47.15
$38.00
$75.53
$2.46B0.69818,490 shs721,013 shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cerevel Therapeutics Holdings, Inc. stock logo
CERE
Cerevel Therapeutics
0.00%0.00%0.00%0.00%+8.25%
Core Natural Resources, Inc. stock logo
CNR
Core Natural Resources
-0.79%+7.67%-2.73%-3.23%-53.36%
CNX Resources Co. stock logo
CNX
CNX Resources
+1.44%+3.51%+0.28%+4.13%+34.78%
Warrior Met Coal, Inc. stock logo
HCC
Warrior Met Coal
+0.32%-3.05%-3.59%-5.39%-26.87%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Cerevel Therapeutics Holdings, Inc. stock logo
CERE
Cerevel Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
Core Natural Resources, Inc. stock logo
CNR
Core Natural Resources
4.1557 of 5 stars
3.50.01.71.53.02.53.1
CNX Resources Co. stock logo
CNX
CNX Resources
3.5771 of 5 stars
1.81.00.80.02.83.33.1
Warrior Met Coal, Inc. stock logo
HCC
Warrior Met Coal
4.2248 of 5 stars
3.31.01.70.03.11.73.1
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cerevel Therapeutics Holdings, Inc. stock logo
CERE
Cerevel Therapeutics
0.00
N/AN/AN/A
Core Natural Resources, Inc. stock logo
CNR
Core Natural Resources
3.00
Buy$120.8065.43% Upside
CNX Resources Co. stock logo
CNX
CNX Resources
1.60
Reduce$31.58-4.58% Downside
Warrior Met Coal, Inc. stock logo
HCC
Warrior Met Coal
2.50
Moderate Buy$63.6735.85% Upside

Current Analyst Ratings Breakdown

Latest CERE, CNX, CNR, and HCC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/11/2025
Core Natural Resources, Inc. stock logo
CNR
Core Natural Resources
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$80.00
5/13/2025
CNX Resources Co. stock logo
CNX
CNX Resources
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetUnderweight ➝ Underweight$21.00 ➝ $25.00
5/13/2025
CNX Resources Co. stock logo
CNX
CNX Resources
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetUnderperform ➝ Underperform$35.00 ➝ $36.00
5/9/2025
Core Natural Resources, Inc. stock logo
CNR
Core Natural Resources
Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$112.00 ➝ $105.00
5/7/2025
Warrior Met Coal, Inc. stock logo
HCC
Warrior Met Coal
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$68.00 ➝ $50.00
4/25/2025
CNX Resources Co. stock logo
CNX
CNX Resources
Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
4/22/2025
CNX Resources Co. stock logo
CNX
CNX Resources
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetUnderweight ➝ Underweight$22.00 ➝ $21.00
4/15/2025
CNX Resources Co. stock logo
CNX
CNX Resources
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingUnderweight ➝ Underweight$31.00
4/11/2025
Core Natural Resources, Inc. stock logo
CNR
Core Natural Resources
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$136.00 ➝ $119.00
4/11/2025
CNX Resources Co. stock logo
CNX
CNX Resources
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeSector Underperform ➝ Sector Perform$33.00
4/11/2025
Warrior Met Coal, Inc. stock logo
HCC
Warrior Met Coal
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$86.00 ➝ $76.00
(Data available from 6/17/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cerevel Therapeutics Holdings, Inc. stock logo
CERE
Cerevel Therapeutics
N/AN/AN/AN/A$3.71 per shareN/A
Core Natural Resources, Inc. stock logo
CNR
Core Natural Resources
$2.62B1.47$25.99 per share2.81$43.32 per share1.69
CNX Resources Co. stock logo
CNX
CNX Resources
$1.67B2.86$5.85 per share5.66$27.53 per share1.20
Warrior Met Coal, Inc. stock logo
HCC
Warrior Met Coal
$1.32B1.86$7.80 per share6.01$39.79 per share1.18
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cerevel Therapeutics Holdings, Inc. stock logo
CERE
Cerevel Therapeutics
-$432.84M-$2.73N/AN/AN/AN/A-98.94%-45.07%N/A
Core Natural Resources, Inc. stock logo
CNR
Core Natural Resources
$655.89M$4.847.604.15N/A12.81%23.87%12.66%N/A
CNX Resources Co. stock logo
CNX
CNX Resources
-$90.49M-$2.06N/A12.310.42-7.14%6.72%3.31%7/24/2025 (Estimated)
Warrior Met Coal, Inc. stock logo
HCC
Warrior Met Coal
$250.60M$2.019.785.23N/A16.43%12.56%10.10%7/30/2025 (Estimated)

Latest CERE, CNX, CNR, and HCC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2025Q1 2025
Core Natural Resources, Inc. stock logo
CNR
Core Natural Resources
$1.74-$1.38-$3.12-$1.38$964.15 million$1.02 billion
4/30/2025Q1 2025
Warrior Met Coal, Inc. stock logo
HCC
Warrior Met Coal
-$0.05-$0.16-$0.11-$0.16$296.39 million$299.94 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Cerevel Therapeutics Holdings, Inc. stock logo
CERE
Cerevel Therapeutics
N/AN/AN/AN/AN/A
Core Natural Resources, Inc. stock logo
CNR
Core Natural Resources
$0.400.55%N/A8.26%N/A
CNX Resources Co. stock logo
CNX
CNX Resources
$0.130.38%N/AN/A N/A
Warrior Met Coal, Inc. stock logo
HCC
Warrior Met Coal
$0.320.68%N/A15.92%1 Years

Latest CERE, CNX, CNR, and HCC Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/24/2025
Core Natural Resources, Inc. stock logo
CNR
Core Natural Resources
$0.100.57%5/30/20256/2/20256/13/2025
4/23/2025
Warrior Met Coal, Inc. stock logo
HCC
Warrior Met Coal
quarterly$0.080.65%5/5/20255/5/20255/12/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cerevel Therapeutics Holdings, Inc. stock logo
CERE
Cerevel Therapeutics
0.60
10.22
10.22
Core Natural Resources, Inc. stock logo
CNR
Core Natural Resources
0.05
1.38
1.16
CNX Resources Co. stock logo
CNX
CNX Resources
0.45
0.33
0.32
Warrior Met Coal, Inc. stock logo
HCC
Warrior Met Coal
0.09
5.20
3.99

Institutional Ownership

CompanyInstitutional Ownership
Cerevel Therapeutics Holdings, Inc. stock logo
CERE
Cerevel Therapeutics
87.73%
Core Natural Resources, Inc. stock logo
CNR
Core Natural Resources
86.54%
CNX Resources Co. stock logo
CNX
CNX Resources
95.16%
Warrior Met Coal, Inc. stock logo
HCC
Warrior Met Coal
92.28%

Insider Ownership

CompanyInsider Ownership
Cerevel Therapeutics Holdings, Inc. stock logo
CERE
Cerevel Therapeutics
5.10%
Core Natural Resources, Inc. stock logo
CNR
Core Natural Resources
1.41%
CNX Resources Co. stock logo
CNX
CNX Resources
3.10%
Warrior Met Coal, Inc. stock logo
HCC
Warrior Met Coal
2.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
Cerevel Therapeutics Holdings, Inc. stock logo
CERE
Cerevel Therapeutics
300182.20 million172.90 millionOptionable
Core Natural Resources, Inc. stock logo
CNR
Core Natural Resources
2,02052.66 million28.98 millionOptionable
CNX Resources Co. stock logo
CNX
CNX Resources
470144.72 million144.23 millionOptionable
Warrior Met Coal, Inc. stock logo
HCC
Warrior Met Coal
85052.56 million52.02 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Cerevel Therapeutics stock logo

Cerevel Therapeutics NASDAQ:CERE

Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, develops various therapies for neuroscience diseases in the United States. It is developing Emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-concept trial in patients with drug-resistant focal onset seizures or focal epilepsy, as well as in phase 1 trial to treat panic symptoms model. The company's products also comprise Tavapadon, a selective dopamine D1/D5 partial agonist that is in phase 3 clinical trial for the treatment of early- and late-stage Parkinson's disease; CVL-871, a selective dopamine D1/D5 partial agonist, which is in Phase 2a clinical trial to treat dementia-related apathy; and CVL-354, a selective kappa-opioid receptor antagonist to treat major depressive disorder and substance use disorder. It is also involved in the development of an M4 agonist program for the treatment of psychosis and related indications; and PDE4 inhibitor for the treatment of psychiatric, neuroinflammatory, and other disorders. Cerevel Therapeutics Holdings, Inc. was founded in 2018 and is headquartered in Cambridge, Massachusetts.

Core Natural Resources stock logo

Core Natural Resources NYSE:CNR

$73.02 -0.78 (-1.06%)
As of 06/16/2025 03:52 PM Eastern

Core Natural Resources, Inc., together with its subsidiaries, produces and sells bituminous coal in the United States and internationally. It operates through two segments, Pennsylvania Mining Complex (PAMC) and CONSOL Marine Terminal. The company's PAMC segment engages in the mining, preparing, and marketing of bituminous coal to power generators, industrial end-users, and metallurgical end-users. This segment includes the Bailey Mine, the Enlow Fork Mine, the Harvey Mine, and the central preparation plant. Its CONSOL Marine Terminal segment provides coal export terminal services through the Port of Baltimore. The company also develops and operates the Itmann Mining Complex located in Wyoming County, West Virginia; and Greenfield Reserves and Resources located in the Northern Appalachian, Central Appalachian, and Illinois basins. The company was formerly known as CONSOL Energy Inc. and changed its name to Core Natural Resources, Inc. in January 2025. Core Natural Resources, Inc. was founded in 1864 and is headquartered in Canonsburg, Pennsylvania.

CNX Resources stock logo

CNX Resources NYSE:CNX

$33.10 +0.44 (+1.35%)
Closing price 06/16/2025 03:59 PM Eastern
Extended Trading
$33.23 +0.13 (+0.39%)
As of 04:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CNX Resources Corporation, an independent natural gas and midstream company, engages in the acquisition, exploration, development, and production of natural gas properties in the Appalachian Basin. The company operates in two segments, Shale and Coalbed Methane (CBM). It produces and sells pipeline quality natural gas primarily for gas wholesalers. The company owns rights to extract natural gas from shale properties in Pennsylvania, West Virginia, and Ohio, as well as rights to extract natural gas from other shale and shallow oil and gas formations in Illinois, Indiana, New York, and Virginia. It also owns rights to extract CBM in Virginia, West Virginia, Pennsylvania, Ohio, Illinois, Indiana, and New Mexico. In addition, the company designs, builds, and operates natural gas gathering systems to move gas from the wellhead to interstate pipelines or other local sales points; owns and operates approximately 2,600 miles of natural gas gathering pipelines, as well as various natural gas processing facilities. It also offers turn-key solutions for water sourcing, delivery, and disposal for its natural gas operations and for third parties. The company was formerly known as CONSOL Energy Inc. and changed its name to CNX Resources Corporation in November 2017. CNX Resources Corporation was founded in 1860 and is headquartered in Canonsburg, Pennsylvania.

Warrior Met Coal stock logo

Warrior Met Coal NYSE:HCC

$46.86 +0.07 (+0.16%)
Closing price 06/16/2025 03:59 PM Eastern
Extended Trading
$46.88 +0.01 (+0.02%)
As of 04:04 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Warrior Met Coal, Inc. produces and exports non-thermal metallurgical coal for the steel industry. It operates two underground mines located in Alabama. The company sells its metallurgical coal to a customer base of blast furnace steel producers located primarily in Europe, South America, and Asia. It also sells natural gas, which is extracted as a byproduct from coal production. Warrior Met Coal, Inc. was incorporated in 2015 and is headquartered in Brookwood, Alabama.